Background: Anxiety is the most common psychiatric disorder which can be cured by herbal and chemical medicine. Herbal medicine and complementary medicine are widely used among people suffering from anxiety disorder. Valeriana officinalis known to cause anxiolytic and sedative effects to have a special place in traditional Chinese, Indian and Iranian medicine. Aims: This study aims to compare the anxiolytic effect of aqueous extract of root of V. officinalis root with Buspirone in mature male mice.
INTRODUCTION
With the industrialization of countries, anxiety is currently rising in people. Anxiety disorders affect 40 million people in the United States (U.S.). It is the most common group of mental illnesses in the country. However, only 36.9 percent of people with the condition receive treatment. These changes include diffuse, unpleasant and vague feelings of panic, along with autonomic symptoms such as confusion, sweating, diarrhoea, increased blood pressure, palpitations, mydriasis, restlessness, tremor, increased heart rate, frequent urination, numbness and syncope. Anxiety is considered a disorder when it occurs in situations where there is no real risk or lasts more than usual after overcoming the risky situation [1] .
The American Psychological Association (APA) defines anxiety as "an emotion characterised by feelings of tension, worried thoughts and physical changes like increased blood pressure." Anxiety disorder is a mental state or severe arousal, the main characteristic of which is fear, doubt and excessive worry. The characteristics of anxiety disorders are: the amount of fear more than the risk, the person is constantly in a state of fear and concern without any specific cause, there are chronic fear and concern and constantly afflicts the person to the extent that he cannot live his everyday life [2] .
In other words, anxiety refers to a state of distress and unpleasant inner feeling, which appears on physiological, psychological and cognitive levels and disrupts normal activities [3] . Biological assumptions usually rely on objective criteria which compare brain function in patients with anxiety disorder with normal people. It is believed that the state of anxiety increases the activity of gamma-Aminobutyric acid (GABA), the main inhibitor of the brain. In emotional and anxiety conditions, changes in limbic system function and activation of hypothalamic-pituitary axis is followed by a change in the adrenal cortex of plasma level of glucocorticoid hormone. These hormones can intervene in brain functions and produce the necessary responses to anxiety. On the other hand, there are many pieces of evidence which suggest that different neurotransmitter systems and neuronal circuits in brain regions, including the components of limbic system, play an important role in the mediation of anxiety behaviours [4] . There is a significant relationship between the levels of GABA in the brain and anxiety, as benzodiazepine used as a sedative drug for the past decades, emulates GABA [5] . Buspirone is not chemically and pharmaceutically similar to benzodiazepines, barbiturates and other sedative agents. Unlike benzodiazepine sedatives, Buspirone has no effect on muscle relaxation and drowsiness. Buspirone is thought to have a strong tendency for serotonin receptors (5-HT1A), but it does not have a significant tendency for benzodiazepine receptors. Buspirone also has a moderate tendency for brain dopamine receptors (D2).
Medicinal herbs have been used for the treatment of diseases in humans. It is estimated that more than 10% of thousands of well-known plant species have drug use. The World Health Organization (WHO) estimates that about 80% of the world's population uses medicinal herbs for aspects of their health care [6, 7] . Valeriana officinalis, scientifically called Nardostachy jatamansi, belonging to the Valerianceae family, grows in temperate regions of the Northern Hemisphere, including Iran [8] .
The roots and rhizomes of this plant are used in traditional medicine to treat various discomforts, including neurological disorders such as epilepsy, insomnia (Valerian is most commonly used for sleep disorders, especially the inability to sleep (insomnia), dizziness, palpitations, and sedation [9] . Many compounds have been identified in the extract of this plant. The most important of these are valproates, isovalproates and divalproates. Other components make up only 0.4% of the extract. Recently, sedative effects of V. officinalis are attributed to its volatile oils, including valerenal and valerenic acid. Sedative effects of V. officinalis have been noted in the ancient Greek books, including Hippocrates and trials conducted confirm these effects; in traditional medicine, the use of this plant dates back to thousands of years [8] . V. officinalis has been known for its anticonvulsant, sedative, anti-hysteria, and palpitation reducing effects. In 1981, Dell Logia stated that root and rhizome extract of N. jatamansi had a weakening effect on the mouse brain. Biochemical studies show that valerenic acid inhibits the enzyme responsible for GABA catabolism and increases GABA concentration in the brain tissue. Increasing the GABA concentration in the brain reduces the activity of various brain nuclei and causes sedative effects [10] . In this regard, studies on experimental animals have shown that sedative and anxiolytic effects of V. officinalis extract are due to compounds such as valerenic acid and valepotriate; moreover, valerian extracts increase by GABA neurotransmitters in the brain. GABA reduces the activity of the nervous system with its inhibitory effect, resulting in sedation, anticonvulsant and anti-anxiety effects [11] . Buspirone is an anti-anxiety drug which has a high tendency for serotonin receptor type (1 A) and a moderate effect on dopaminergic system and a relative agonist effect on alpha-adrenergic receptors.
According to the studies on sedative effects of V. officinalis and taking steps to develop utilization of medicinal plants with fewer complications for patients, and moreover, given the need to introduce an agent which can be effectively used instead of or in combination with other sedative drugs. The present study tends to test the relationship between anxiolytic effects of the root of V. officinalis and buspirone administered in the treatment of anxiety. Studying the effect of hydroalcoholic extract of V. officinalis on astrocyteos of hippocampus formations of Rats, Roozbehi et al. [12] concluded that this extracted compounds such as phenolic acid, esters, flavonoids, monoterpenes and sesquiterpenes, and antioxidant properties can affect the extracellular neuronal environment and proliferate astrocyte cells.
Khajehpour et al. [13] studied adrenergic interference in anxiolytic effect of hydroalcoholic extract of V. officinalis root and showed that injection of this extract reduces anxiety behaviour by increasing the elapsed time percentage in the open arm and percentage of arrival into this arm. Moreover, injection of epinephrine prior to V. officinalis extract reduced its anxiolytic effect, while the same dose of epinephrine alone did not affect anxiety. As a result, it can be argued that central adrenergic mechanisms may be involved in the reduction of anxiety behaviours due to hydroalcoholic extract of this plant. Gromball et al. [16] studied improvement in hyperactivity, concentration difficulties and impulsiveness during a seven-week treatment with valerian root and lemon balm extracts in primary school children. They concluded that this extract hopefully can lead to durable treatment in children. In addition, this method is very effective in improving the educational subject.
Min Nam et al. [17] studied V. officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation. V. officinalis used in traditional and herbal medicine in many cultures. It seems that V. officinalis and valerenic acid enhance cognitive function, promote cell proliferation and neuroblast differentiation, and also decrease serum corticosterone and lipid peroxidation in elde mice.
Evaluating the effectiveness of high valerenic acid and low acetoxy valerenic acid contents in reducing anxiolytic activity, Felgentreff et al. [18] concluded that this plant is widely used in the treatment of insomnia and anxiety and it is significantly effective in decreasing anxiolytic activities, and this effect is also more pronounced than valerenic acid.
Surajit et al. [19] evaluated effectiveness of Valeriana wallichii root extract in improving sleep quality and modulating brain monoamine in rats and showed that this extract can positively improve sleep quality on two levels of the brain, cortex and stem. This present study aims to compare the anxiolytic effect of aqueous extract of Valeriana officinalis root with Buspirone in mature male mice.
MATERIALS AND METHODS
In this study, 30 mature male mice were randomly divided into 5 groups of 6. A total of 30 mature male mice with a weight range of 25 
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MATERIALS AND METHODS
In this study, 30 mature male mice were randomly divided into 5 groups of 6. A total of 30 mature male mice with a weight range of 25-35 g were moved from Islamic Azad University of Mashhad to an animal room of the F Basic Sciences, Azad University of Nishabur, Northeast Iran, under standard conditions ( Fig  1) . The mice were kept under controlled light conditions (12 hours of light and 12 hours of darkness), 70% relative humidity and 22 ± 3°C for 10 days. Standard plates were used to feed the mice by sufficient mouse feed (Javaneh Khorasan Company) and drinking water.
To make extracts, V. officinalis purchased from Apothicaire; genus and species were determined by the Department of Botany of the Faculty of Basic Sciences, Islamic Azad University of Neishabour. The plant was then powdered by an electric mill; 500 mg dry powder was moved to a 5000 ml beaker and soaked in 1 lit distilled water. It was incubated at 35°C for 72 h and stirred every day. Then, it was filtered by using filter paper and vacuum pump and Büchner funnel. The filtered liquid was poured into a large tray and placed in an oven at 30-35°C for 24 h to remove the solvent to collect the condensed solution and the honey extract and keep it in the freezer.
The mice were randomly placed in cages in order; to study anxiolytic effects of extract of V. officinalis and compare with buspirone, the mice were randomly assigned to 5 groups of 6 after 10 days. List of the treatment group and its corresponding experimental design has been depicted in Table 1 .
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Treatment group A 100 mg/kg aqueous extract of Valeriana officinalis was added to drinking water from day one to end of experiment 3.
Treatment group B 200 mg/kg aqueous extract of Valeriana officinalis was added to drinking water from day one to end of the experiment 4.
Treatment group C 300 mg/kg aqueous extract of Valeriana officinalis was added to drinking water from day one to end of experiment 5.
Treatment group BUS 30 mg/kg Buspirone was added to drinking water from day one to end of experiment A 5 mg tablet of Buspirone was purchased from the pharmacy; given that the consumed dose is 30 mg/kg, the required dose for each mouse was first calculated according to its weight.
X=0.9 1000 g 30 mg dosage 30 g weight of each mouse X dosage per mice
To make an aqueous extract of V. officinalis root (100 mg/kg), the dose per mice was calculated according to its weight. Then, the calculated value was accurately measured by a digital scale and solved in drinking water of the mice. To make an aqueous extract of V. officinalis root (300 mg/kg), the dose per mice was calculated according to its weight. Then, the calculated value was accurately measured by a digital scale and solved in drinking water of the mice. X=9 1000 g 300 Mg 30 g weight of each mouse X An elevated plus maze which is a standard model for investigating the anxiety behaviour in rodents was used to assess anxiety. This experimental model measures unconditional anxiety and does not need the animal to train and learn [20] . The metal maze consisted of two open arms (each 10×50 cm) and two closed arms (each 10×50 cm) and height of the closed arms was 10 cm. The junction of two arms was a square-shaped space (10×10 cm). The device was about 50 cm above the floor. The light was provided by a 100 watt lamp located at an altitude of 120 cm from the plus maze [21] . Duration of the presence of mice on open arms was a marker of non-anxiety and duration of the presence of mice (arrival to each arm was the time when the head and both hands reach the arm to the center of gravity of the body) on closed arms was an anxiety marker [22] .
For 10 days, buspirone and aqueous extract of V. officinalis were prepared daily and added to drinking water and enough food was placed; moisture, temperature and light were controlled every day. Ten days after receiving the drug, the mice were moved from the animal room to the anxiety testing laboratory (Animal Laboratory of the Faculty of Basic Sciences, Islamic Azad University, Neishabour Branch) one hour before the test (in order to adapt to the environment); before and after the experiment, it was attempted to provide a low-stress environment.
Each animal was placed in the middle of the central chassis in front of an open arm; for 5 min, movements and behaviour of the animal were recorded by a camera mounted on top of the maze and the video was automatically stored on the computer system connected to the maze and the camera. Each animal was used only once in the experiment. After completing each test, all parts of the device which was in contact with the mouse were cleaned and dried with cotton and alcohol; then the next mouse was placed in the device. All experiments were carried out within a time interval of 8-14. In all experiments, the ethics guidelines recommended by the International Veterinary Academy of Pain Management were observed.
RESULTS
In order to describe the data, descriptive statistical method (mean, median, mode and standard deviation) was performed by software which was installed on the computer system connected to the camera and the maze system. In order to test the hypotheses, inferential statistics of one way ANOVA and T-Test were used; for analyzing the data, the SPSS 19 statistical program was used and charts were drawn by Excel software (2010). Table 2 shows the mean and standard deviation of the anxiety scores in the groups SH, A, B, C and BUS.
As Table 2 shows, mean of the groups A, B, BUS, C and SH are 87.39, 76.81, 74.96, 62.38 and 92.80, respectively; moreover, standard deviation of the groups A, B, BUS, C and SH are 8.52, 15.03, 6.38, 9.55 and 11.96, respectively. Fig. 2 shows column chart of anxiety score in the groups A, B, BUS, C and SH. 
Testing Normality of Variables and Homogeneity of Variances
Shapiro-wilk test was used to test the normality of data (Table 3) and Levene test was used to test the homogeneity of anxiety in the studied groups ( Table 3 ).
As Table 3 shows, data is normally distributed (p<0.05).
As Table 4 shows, Levene's W=1.66; thus, the variances are homogeneous (p>0.05).
Hypothesis Testing
There is a significant difference in anxiolytic effect of aqueous extract of Valeriana officinalis root and Buspirone in mice.
To test this hypothesis, ANOVA was used as shown in Table 5 .
As shown in Table 5 , F-value=2.91 and P-value=0.04 supports the hypothesis; it can be claimed that there is a significant difference in the anxiolytic effect of aqueous extract of Valeriana officinalis root and Buspirone in mice.
Sub-hypothesis 1
There is a significant difference in the anxiolytic effect of 100 mg/kg aqueous extract of Valeriana officinalis root and 30 mg/kg Buspirone in mice.
T-test was used to examine the first subhypothesis ( Table 6) .
As the Table 6 shows, the first sub-hypothesis is rejected (p-value=0.35).
Sub-hypothesis 2
There is a significant difference in anxiolytic effect of 200 mg/kg aqueous extract of Valeriana officinalis root and 30 mg/kg Buspirone in mice.
T-test was used to examine the second subhypothesis (Table 7) . As the Table 7 shows, the second subhypothesis is rejected (p-value=0.89).
Sub-hypothesis 3
There is a significant difference in the anxiolytic effect of 300 mg/kg aqueous extract of V. officinalis root and 30 mg/kg Buspirone in mice.
T-test was used to examine the third subhypothesis ( Table 8) .
As the Table 8 shows, the third sub-hypothesis is accepted (t-value=-2.93; p-value=0.001). Thus, there is a significant difference in anxiolytic effect of 300 mg/kg aqueous extract of V. officinalis root and 30 mg/kg Buspirone in mice (p<0.05).
DISCUSSION
Medicinal plants currently form an important part of traditional medicine in many countries and they have a special place in new therapeutic approaches. In order to explain the main hypothesis based on scientific documents after intervention on all experimental and control groups according to Table 5 , ANOVA and T-test results showed a significant relationship between anxiolytic effect of aqueous extract of V. officinalis root and Buspirone in mice. The results show that aqueous extract of V. officinalis root causes a significant increase in the number of arrivals and elapsed time in open arms compared to Buspirone. Therefore, it can be concluded that V. officinalis is more effective than Buspirone in reducing anxiety.
The first sub-hypothesis indicated a significant difference in anxiolytic effect of 100 mg/kg aqueous extract of V. officinalis root and 10 mg/kg buspirone in mice. According to the results listed in The third sub-hypothesis indicated a significant difference in anxiolytic effect of 300 mg/kg aqueous extract of V. officinalis root and 30 mg/kg buspirone in mice. According to the results listed in Table 8 , p-value=0.001 (p<0.05) does not support the assumption of equal means between groups C and BUS. The results show that 300 mg/kg aqueous extract of V. officinalis root caused a significant increase in the number of arrivals and elapsed time of animals in open arms, compared to 30 mg/kg buspirone; therefore, there is a significant difference in anxiolytic effect of 300 mg/kg aqueous extract of V. officinalis root and 30 mg/kg buspirone in mice. In other words, 300 mg/kg aqueous extract of V. officinalis and 30 mg/kg Buspirone were not equally effective in reducing anxiety; instead, 300 mg/kg extract further reduced anxiety and had a higher effect.
CONCLUSION
This study tended to compare the anxiolytic effect of aqueous extract of Valencia officinalis root with Buspirone in mice. Medicinal plants currently form an important part of traditional medicine in many countries and they have a special place in new therapeutic approaches. The results showed that aqueous extract of V. officinalis root causes a significant increase in the number of arrivals and elapsed time in open arms compared to Buspirone. ANOVA and T-test results showed a significant relationship between the anxiolytic effect of aqueous extract of V. officinalis root and Buspirone in mice. Therefore, it can be concluded that V. officinalis is more effective than Buspirone in reducing anxiety.
It can be concluded that V. officinalis is more effective in reducing anxiety compared to buspirone.
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